ATC codes:
L01BB02
EMLc
Indication
Lymphoid leukaemia, not elsewhere classified
ICD11 code:
2C03.3
INN
Mercaptopurine
Medicine type
Chemical agent
List type
Complementary
Formulations
Oral > Solid:
50 mg tablet
EML status history
First added in 2015
(TRS
994)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for mercaptopurine on the complementary list of the EML and EMLc for use in treatment protocols for acute lymphoblastic leukaemia was endorsed. The relevant extract from TRS994 regarding the Expert Committee's consideration of treatment protocols for acute lymphoblastic leukaemia is attached.